Luminescence screening assays have become a central component of modern drug discovery workflows, particularly in high-throughput screening (HTS) environments. These assays enable rapid, sensitive ...

MADISON, Wis.--(BUSINESS WIRE)--Researchers working with bioluminescence now have a more accessible and cost-effective tool for their studies. The newly launched MyGlo™ Reagent Reader from Promega ...

Microplate readers play a crucial role in the life sciences and biotechnology industry due to their ability to measure biological, biochemical or chemical reactions efficiently and in high throughput.

The CellTiter-Glo ® 2.0 Cell Viability Assay is a luminescent method for swift, convenient, routine cell viability assessments. Offers equivalent performance to the classic CellTiter-Glo ® Cell ...

Join our team for an exclusive unboxing and preview of the Byonoy Luminescence 96 Luminometer. Explore its innovative design and cutting-edge technology, setting new standards for luminescence assays.

Tumor necrosis factor alpha (TNFα) is a potent cytokine involved in immune surveillance and function. Dysregulated TNFα levels have been implicated in chronic diseases such as rheumatoid arthritis, ...

Gprotein-coupled receptors (GPCRs) are an important class of receptor in modern drug discovery. This superfamily of receptors is highly tractable for drug discovery purposes because many of these ...

Traditional enzymatic assays are often technologically limited by plate readers with narrow detection ranges that only capture either faint or intense signals, forcing researchers into laborious and ...

MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation launches a new assay validated for assessing the viability of cells in three-dimensional (3D) microtissue model systems. CellTiter-Glo® 3D Cell ...